Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014)
Sarepta Therapeutics' (SRPT) quarterly Depreciation and Depletion came in at $400000.0 in Q1 2014, up 33.33% year-on-year from $300000.0 in Q1 2013, and up 33.33% quarter-over-quarter from $300000.0 in Q1 2013.
Sarepta Therapeutics (SRPT) Depreciation and Depletion (2013 - 2014) Analysis & Trends
Sarepta Therapeutics' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $400000.0 for Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 400,000.00 |
| Mar 31, 2014 | 400,000.00 |
| Mar 31, 2013 | 300,000.00 |
| Mar 31, 2013 | 300,000.00 |